Download PDF
Horm Metab Res 2013; 45(13): 1002-1008
DOI: 10.1055/s-0033-1351325
Review
© Georg Thieme Verlag KG Stuttgart · New York

The Role of Obestatin in Glucose and Lipid Metabolism

E. Gargantini
1   Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Torino, Torino, Italy
,
C. Grande
1   Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Torino, Torino, Italy
,
L. Trovato
1   Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Torino, Torino, Italy
,
E. Ghigo
1   Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Torino, Torino, Italy
,
R. Granata
1   Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Torino, Torino, Italy
› Author Affiliations
Further Information

Publication History

received 16 May 2013

accepted 08 July 2013

Publication Date:
15 August 2013 (online)

Also available at
    Permissions and Reprints

Abstract

Obestatin is a 23 amino acid peptide encoded by the ghrelin gene, which, like ghrelin, is mainly produced by the stomach, as well as by a wide range of other tissues. Obestatin remains a controversial peptide, as the initial finding of its binding to the orphan receptor GPR39 and the inhibitory effect on food intake has been questioned. In fact, to date, its biological effects are still largely unknown, although it is becoming clear that obestatin is a pleiotropic hormone, exerting a variety of effects in different cell types and tissues. Indeed, besides regulating cell proliferation and survival, obestatin has been shown to regulate glucose and lipid metabolism, both in vitro, in pancreatic β-cells and adipocytes, and in vivo in rodents. Furthermore, its positive effects on glucose homeostasis, combined with the anti-inflammatory actions, make this peptide appealing as a candidate for treating metabolic disorders such as insulin resistance and diabetes.

Key words

beta cells - insulin sensitivity - insulin secretion - adipogenesis - lipid metabolism - human adipose tissue
 

  • References

  • 1 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660
    CrossrefPubMedGoogle Scholar
  • 2 Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE, Hale JE. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 2008; 105: 6320-6325
    CrossrefPubMedGoogle Scholar
  • 3 Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008; 132: 387-396
    CrossrefPubMedGoogle Scholar
  • 4 Seim I, Josh P, Cunningham P, Herington A, Chopin L. Ghrelin axis genes, peptides and receptors: recent findings and future challenges. Mol Cell Endocrinol 2011; 340: 3-9
    CrossrefPubMedGoogle Scholar
  • 5 Delhanty PJ, Neggers SJ, van der Lely AJ. Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin. Eur J Endocrinol 2012; 167: 601-608
    CrossrefPubMedGoogle Scholar
  • 6 Granata R, Gallo D, Luque RM, Baragli A, Scarlatti F, Grande C, Gesmundo I, Cordoba-Chacon J, Bergandi L, Settanni F, Togliatto G, Volante M, Garetto S, Annunziata M, Chanclon B, Gargantini E, Rocchietto S, Matera L, Datta G, Morino M, Brizzi MF, Ong H, Camussi G, Castano JP, Papotti M, Ghigo E. Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. FASEB J 2012; 26: 3393-3411
    CrossrefPubMedGoogle Scholar
  • 7 Granata R, Baragli A, Settanni F, Scarlatti F, Ghigo E. Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J Mol Endocrinol 2010; 45: 107-118
    CrossrefPubMedGoogle Scholar
  • 8 Granata R, Settanni F, Julien M, Nano R, Togliatto G, Trombetta A, Gallo D, Piemonti L, Brizzi MF, Abribat T, van Der Lely AJ, Ghigo E. Des-acyl ghrelin fragments and analogues promote survival of pancreatic beta-cells and human pancreatic islets and prevent diabetes in streptozotocin-treated rats. J Med Chem 2012; 55: 2585-2596
    CrossrefPubMedGoogle Scholar
  • 9 Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 2004; 101: 4679-4684
    CrossrefPubMedGoogle Scholar
  • 10 Muccioli G, Baragli A, Granata R, Papotti M, Ghigo E. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology 2007; 86: 147-164
    CrossrefPubMedGoogle Scholar
  • 11 Lacquaniti A, Donato V, Chirico V, Buemi A, Buemi M. Obestatin: an interesting but controversial gut hormone. Ann Nutr Metab 2011; 59: 193-199
    CrossrefPubMedGoogle Scholar
  • 12 Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002; 159: 1029-1037
    CrossrefPubMedGoogle Scholar
  • 13 Filigheddu N, Gnocchi VF, Coscia M, Cappelli M, Porporato PE, Taulli R, Traini S, Baldanzi G, Chianale F, Cutrupi S, Arnoletti E, Ghe C, Fubini A, Surico N, Sinigaglia F, Ponzetto C, Muccioli G, Crepaldi T, Graziani A. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell 2007; 18: 986-994
    CrossrefPubMedGoogle Scholar
  • 14 Granata R, Settanni F, Biancone L, Trovato L, Nano R, Bertuzzi F, Destefanis S, Annunziata M, Martinetti M, Catapano F, Ghe C, Isgaard J, Papotti M, Ghigo E, Muccioli G. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology 2007; 148: 512-529
    CrossrefPubMedGoogle Scholar
  • 15 Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science 2005; 310: 996-999
    CrossrefPubMedGoogle Scholar
  • 16 Zizzari P, Longchamps R, Epelbaum J, Bluet-Pajot MT. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 2007; 148: 1648-1653
    CrossrefPubMedGoogle Scholar
  • 17 Hassouna R, Zizzari P, Viltart O, Yang SK, Gardette R, Videau C, Badoer E, Epelbaum J, Tolle V. A natural variant of obestatin, Q90L, inhibits ghrelin’s action on food intake and GH secretion and targets NPY and GHRH neurons in mice. PLoS ONE 2012; 7: e51135
    CrossrefPubMedGoogle Scholar
  • 18 Bresciani E, Rapetti D, Dona F, Bulgarelli I, Tamiazzo L, Locatelli V, Torsello A. Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J Endocrinol Invest 2006; 29: RC16-RC18
    PubMedGoogle Scholar
  • 19 Green BD, Irwin N, Flatt PR. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 2007; 28: 981-987
    CrossrefPubMedGoogle Scholar
  • 20 Nagaraj S, Peddha MS, Manjappara UV. Fragments of obestatin as modulators of feed intake, circulating lipids, and stored fat. Biochem Biophys Res Commun 2008; 366: 731-737
    CrossrefPubMedGoogle Scholar
  • 21 Zhang JV, Jahr H, Luo CW, Klein C, Van Kolen K, Ver Donck L, De A, Baart E, Li J, Moechars D, Hsueh AJ. Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39. Mol Endocrinol 2008; 22: 1464-1475
    CrossrefPubMedGoogle Scholar
  • 22 Kobelt P, Wisser AS, Stengel A, Goebel M, Bannert N, Gourcerol G, Inhoff T, Noetzel S, Wiedenmann B, Klapp BF, Tache Y, Monnikes H. Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents. Peptides 2008; 29: 1018-1027
    CrossrefPubMedGoogle Scholar
  • 23 Bassil AK, Haglund Y, Brown J, Rudholm T, Hellstrom PM, Naslund E, Lee K, Sanger GJ. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol 2007; 150: 58-64
    PubMedGoogle Scholar
  • 24 De Smet B, Thijs T, Peeters TL, Depoortere I. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil 2007; 19: 211-217
    CrossrefPubMedGoogle Scholar
  • 25 Gourcerol G, St-Pierre DH, Tache Y. Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)?. Regul Pept 2007; 141: 1-7
    CrossrefPubMedGoogle Scholar
  • 26 Chartrel N, Alvear-Perez R, Leprince J, Iturrioz X, Reaux-Le Goazigo A, Audinot V, Chomarat P, Coge F, Nosjean O, Rodriguez M, Galizzi JP, Boutin JA, Vaudry H, Llorens-Cortes C. Comment on “Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake”. Science 2007; 315: 766 authors’ reply 766
    PubMedGoogle Scholar
  • 27 Nogueiras R, Pfluger P, Tovar S, Arnold M, Mitchell S, Morris A, Perez-Tilve D, Vazquez MJ, Wiedmer P, Castaneda TR, DiMarchi R, Tschop M, Schurmann A, Joost HG, Williams LM, Langhans W, Dieguez C. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2007; 148: 21-26
    CrossrefPubMedGoogle Scholar
  • 28 Pan W, Tu H, Kastin AJ. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 2006; 27: 911-916
    CrossrefPubMedGoogle Scholar
  • 29 Ren G, He Z, Cong P, Chen H, Guo Y, Yu J, Liu Z, Ji Q, Song Z, Chen Y. Peripheral administration of TAT-obestatin can influence the expression of liporegulatory genes but fails to affect food intake in mice. Peptides 2013; 42C: 8-14
    PubMedGoogle Scholar
  • 30 Granata R, Settanni F, Gallo D, Trovato L, Biancone L, Cantaluppi V, Nano R, Annunziata M, Campiglia P, Arnoletti E, Ghe C, Volante M, Papotti M, Muccioli G, Ghigo E. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 2008; 57: 967-979
    CrossrefPubMedGoogle Scholar
  • 31 Gronberg M, Tsolakis AV, Magnusson L, Janson ET, Saras J. Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem 2008; 56: 793-801
    CrossrefPubMedGoogle Scholar
  • 32 Volante M, Rosas R, Ceppi P, Rapa I, Cassoni P, Wiedenmann B, Settanni F, Granata R, Papotti M. Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth. J Pathol 2009; 218: 458-466
    CrossrefPubMedGoogle Scholar
  • 33 Zhao CM, Furnes MW, Stenstrom B, Kulseng B, Chen D. Characterization of obestatin- and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res 2008; 331: 575-587
    CrossrefPubMedGoogle Scholar
  • 34 Guo ZF, Ren AJ, Zheng X, Qin YW, Cheng F, Zhang J, Wu H, Yuan WJ, Zou L. Different responses of circulating ghrelin, obestatin levels to fasting, re-feeding and different food compositions, and their local expressions in rats. Peptides 2008; 29: 1247-1254
    CrossrefPubMedGoogle Scholar
  • 35 Dun SL, Brailoiu GC, Brailoiu E, Yang J, Chang JK, Dun NJ. Distribution and biological activity of obestatin in the rat. J Endocrinol 2006; 191: 481-489
    CrossrefPubMedGoogle Scholar
  • 36 Karaoglu A, Aydin S, Dagli AF, Cummings DE, Ozercan IH, Canatan H, Ozkan Y. Expression of obestatin and ghrelin in papillary thyroid carcinoma. Mol Cell Biochem 2009; 323: 113-118
    CrossrefPubMedGoogle Scholar
  • 37 Gurriaran-Rodriguez U, Santos-Zas I, Al-Massadi O, Mosteiro CS, Beiroa D, Nogueiras R, Crujeiras AB, Seoane LM, Senaris J, Garcia-Caballero T, Gallego R, Casanueva FF, Pazos Y, Camina JP. The obestatin/GPR39 system is up-regulated by muscle injury and functions as an autocrine regenerative system. J Biol Chem 2012; 287: 38379-38389
    CrossrefPubMedGoogle Scholar
  • 38 Nakahara T, Harada T, Yasuhara D, Shimada N, Amitani H, Sakoguchi T, Kamiji MM, Asakawa A, Inui A. Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry 2008; 64: 252-255
    CrossrefPubMedGoogle Scholar
  • 39 Uehara M, Yasuhara D, Nakahara T, Harada T, Koyama KI, Ushikai M, Asakawa A, Inui A. Increase in energy intake leads to a decrease in obestatin in restricting-type of anorexia nervosa. Exp Clin Endocrinol Diabetes 2011; 119: 536-539
    Article in Thieme ConnectPubMedGoogle Scholar
  • 40 Monteleone P, Serritella C, Martiadis V, Scognamiglio P, Maj M. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. J Clin Endocrinol Metab 2008; 93: 4418-4421
    CrossrefPubMedGoogle Scholar
  • 41 Germain N, Galusca B, Grouselle D, Frere D, Billard S, Epelbaum J, Estour B. Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. J Clin Endocrinol Metab 2010; 95: 3057-3062
    CrossrefPubMedGoogle Scholar
  • 42 Sedlackova D, Kopeckova J, Papezova H, Vybiral S, Kvasnickova H, Hill M, Nedvidkova J. Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa patients before and after a high-carbohydrate breakfast. Physiol Res 2011; 60: 165-173
    PubMedGoogle Scholar
  • 43 Huda MS, Mani H, Durham BH, Dovey TM, Halford JC, Aditya BS, Pinkney JH, Wilding JP, Hart IK. Plasma obestatin and autonomic function are altered in orexin-deficient narcolepsy, but ghrelin is unchanged. Endocrine 2013; 43: 696-704
    CrossrefPubMedGoogle Scholar
  • 44 Cui AD, Gai NN, Zhang XH, Jia KZ, Yang YL, Song ZJ. Decreased serum obestatin consequent upon TRIB3 Q84R polymorphism exacerbates carotid atherosclerosis in subjects with metabolic syndrome. Diabetol Metab Syndr 2012; 4: 52
    CrossrefPubMedGoogle Scholar
  • 45 Alexandridis E, Zisimopoulos A, Liratzopoulos N, Katsos I, Manolas K, Kouklakis G. Obestatin/ghrelin ratio: a new activity index in inflammatory bowel diseases. Inflamm Bowel Dis 2009; 15: 1557-1561
    CrossrefPubMedGoogle Scholar
  • 46 Gao XY, Kuang HY, Liu XM, Ma ZB, Nie HJ, Guo H. Plasma obestatin levels in men with chronic atrophic gastritis. Peptides 2008; 29: 1749-1754
    CrossrefPubMedGoogle Scholar
  • 47 Ulasoglu C, Isbilen B, Doganay L, Ozen F, Kiziltas S, Tuncer I. Effect of Helicobacter pylori eradication on serum ghrelin and obestatin levels. World J Gastroenterol 2013; 19: 2388-2394
    CrossrefPubMedGoogle Scholar
  • 48 Gronberg M, Tsolakis AV, Holmback U, Stridsberg M, Grimelius L, Janson ET. Ghrelin and obestatin in human neuroendocrine tumors: expression and effect on obestatin levels after food intake. Neuroendocrinology 2013; 97: 291-299
    CrossrefPubMedGoogle Scholar
  • 49 Lauwers E, Landuyt B, Arckens L, Schoofs L, Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 2006; 351: 21-25
    CrossrefPubMedGoogle Scholar
  • 50 Holst B, Egerod KL, Schild E, Vickers SP, Cheetham S, Gerlach LO, Storjohann L, Stidsen CE, Jones R, Beck-Sickinger AG, Schwartz TW. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 2007; 148: 13-20
    CrossrefPubMedGoogle Scholar
  • 51 Zhang JV, Li L, Huang Q, Ren PG. Obestatin receptor in energy homeostasis and obesity pathogenesis. Prog Mol Biol Transl Sci 2013; 114: 89-107
    PubMedGoogle Scholar
  • 52 Drucker DJ. The biology of incretin hormones. Cell Metab 2006; 3: 153-165
    CrossrefPubMedGoogle Scholar
  • 53 Alloatti G, Arnoletti E, Bassino E, Penna C, Perrelli MG, Ghe C, Muccioli G. Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes. Am J Physiol Heart Circ Physiol 2010; 299: H470-H481
    CrossrefPubMedGoogle Scholar
  • 54 Iglesias MJ, Salgado A, Pineiro R, Rodino BK, Otero MF, Grigorian L, Gallego R, Dieguez C, Gualillo O, Gonzalez-Juanatey JR, Lago F. Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism. J Endocrinol Invest 2007; 30: 470-476
    PubMedGoogle Scholar
  • 55 Samson WK, White MM, Price C, Ferguson AV. Obestatin acts in brain to inhibit thirst. Am J Physiol Regul Integr Comp Physiol 2007; 292: R637-R643
    PubMedGoogle Scholar
  • 56 Carlini VP, Schioth HB, Debarioglio SR. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun 2007; 352: 907-912
    CrossrefPubMedGoogle Scholar
  • 57 Szentirmai E, Krueger JM. Obestatin alters sleep in rats. Neurosci Lett 2006; 404: 222-226
    CrossrefPubMedGoogle Scholar
  • 58 Camina JP, Campos JF, Caminos JE, Dieguez C, Casanueva FF. Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms. J Cell Physiol 2007; 211: 1-9
    CrossrefPubMedGoogle Scholar
  • 59 Pazos Y, Alvarez CJ, Camina JP, Casanueva FF. Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-III by obestatin. Growth Factors 2007; 25: 373-381
    CrossrefPubMedGoogle Scholar
  • 60 Granata R, Volante M, Settanni F, Gauna C, Ghe C, Annunziata M, Deidda B, Gesmundo I, Abribat T, van der Lely AJ, Muccioli G, Ghigo E, Papotti M. Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats. J Mol Endocrinol 2010; 45: 9-17
    CrossrefPubMedGoogle Scholar
  • 61 Favaro E, Granata R, Miceli I, Baragli A, Settanni F, Cavallo Perin P, Ghigo E, Camussi G, Zanone MM. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways. Diabetologia 2012; 55: 1058-1070
    CrossrefPubMedGoogle Scholar
  • 62 Baragli A, Grande C, Gesmundo I, Settanni F, Taliano M, Gallo D, Gargantini E, Ghigo E, Granata R. Obestatin enhances in vitro generation of pancreatic islets through regulation of developmental pathways. PLoS ONE 2013; 8: e64374
    CrossrefPubMedGoogle Scholar
  • 63 Gurriaran-Rodriguez U, Al-Massadi O, Roca-Rivada A, Crujeiras AB, Gallego R, Pardo M, Seoane LM, Pazos Y, Casanueva FF, Camina JP. Obestatin as a regulator of adipocyte metabolism and adipogenesis. J Cell Mol Med 2011; 15: 1927-1940
    CrossrefPubMedGoogle Scholar
  • 64 Miegueu St P, Pierre D, Broglio F, Cianflone K. Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J Cell Biochem 2011; 112: 704-714
    CrossrefPubMedGoogle Scholar
  • 65 Pruszynska-Oszmalek E, Szczepankiewicz D, Hertig I, Skrzypski M, Sassek M, Kaczmarek P, Kolodziejski PA, Mackowiak P, Nowak KW, Strowski MZ, Wojciechowicz T. Obestatin inhibits lipogenesis and glucose uptake in isolated primary rat adipocytes. J Biol Regul Homeost Agents 2013; 27: 23-33
    PubMedGoogle Scholar
  • 66 Aragno M, Mastrocola R, Ghe C, Arnoletti E, Bassino E, Alloatti G, Muccioli G. Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. Cardiovasc Diabetol 2012; 11: 129
    CrossrefPubMedGoogle Scholar
  • 67 Granata R, Isgaard J, Alloatti G, Ghigo E. Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone. Exp Biol Med (Maywood) 2011; 236: 505-514
    CrossrefPubMedGoogle Scholar
  • 68 Kellokoski E, Kunnari A, Jokela M, Makela S, Kesaniemi YA, Horkko S. Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding. Metabolism 2009; 58: 1572-1580
    CrossrefPubMedGoogle Scholar
  • 69 Ceranowicz P, Warzecha Z, Dembinski A, Cieszkowski J, Dembinski M, Sendur R, Kusnierz-Cabala B, Tomaszewska R, Kuwahara A, Kato I. Pretreatment with obestatin inhibits the development of cerulein-induced pancreatitis. J Physiol Pharmacol 2009; 60: 95-101
    PubMedGoogle Scholar
  • 70 Granata R, Ghigo E. Products of the Ghrelin Gene, the Pancreatic beta-Cell and the Adipocyte. Endocr Dev 2013; 25: 144-156
    PubMedGoogle Scholar
  • 71 Walia P, Asadi A, Kieffer TJ, Johnson JD, Chanoine JP. Ontogeny of ghrelin, obestatin, preproghrelin, and prohormone convertases in rat pancreas and stomach. Pediatr Res 2009; 65: 39-44
    CrossrefPubMedGoogle Scholar
  • 72 Turk N, Dagistanli FK, Sacan O, Yanardag R, Bolkent S. Obestatin and insulin in pancreas of newborn diabetic rats treated with exogenous ghrelin. Acta Histochem 2012; 114: 349-357
    CrossrefPubMedGoogle Scholar
  • 73 Donath MY, Halban PA. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 2004; 47: 581-589
    CrossrefPubMedGoogle Scholar
  • 74 Hennige AM, Burks DJ, Ozcan U, Kulkarni RN, Ye J, Park S, Schubert M, Fisher TL, Dow MA, Leshan R, Zakaria M, Mossa-Basha M, White MF. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest 2003; 112: 1521-1532
    CrossrefPubMedGoogle Scholar
  • 75 Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, Walker J, Lin X, White M, Montminy M. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 2003; 17: 1575-1580
    CrossrefPubMedGoogle Scholar
  • 76 Cheng H, Straub SG, Sharp GW. Inhibitory role of Src family tyrosine kinases on Ca2+-dependent insulin release. Am J Physiol Endocrinol Metab 2007; 292: E845-E852
    PubMedGoogle Scholar
  • 77 Doyle ME, Egan JM. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther 2007; 113: 546-593
    CrossrefPubMedGoogle Scholar
  • 78 Terauchi Y, Takamoto I, Kubota N, Matsui J, Suzuki R, Komeda K, Hara A, Toyoda Y, Miwa I, Aizawa S, Tsutsumi S, Tsubamoto Y, Hashimoto S, Eto K, Nakamura A, Noda M, Tobe K, Aburatani H, Nagai R, Kadowaki T. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest 2007; 117: 246-257
    CrossrefPubMedGoogle Scholar
  • 79 Wierup N, Svensson H, Mulder H, Sundler F. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 2002; 107: 63-69
    CrossrefPubMedGoogle Scholar
  • 80 Ceranowicz D, Warzecha Z, Dembinski A, Ceranowicz P, Cieszkowski J, Kusnierz-Cabala B, Tomaszewska R, Kuwahara A, Kato I. Role of hormonal axis, growth hormone-IGF-1, in the therapeutic effect of ghrelin in the course of cerulein-induced acute pancreatitis. J Physiol Pharmacol 61: 599-606
    PubMedGoogle Scholar
  • 81 Qader SS, Hakanson R, Rehfeld JF, Lundquist I, Salehi A. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regul Pept 2008; 146: 230-237
    CrossrefPubMedGoogle Scholar
  • 82 Ren AJ, Guo ZF, Wang YK, Wang LG, Wang WZ, Lin L, Zheng X, Yuan WJ. Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem Biophys Res Commun 2008; 369: 969-972
    CrossrefPubMedGoogle Scholar
  • 83 Egido EM, Hernandez R, Marco J, Silvestre RA. Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas. Regul Pept 2009; 152: 61-66
    CrossrefPubMedGoogle Scholar
  • 84 Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85-97
    CrossrefPubMedGoogle Scholar
  • 85 Bourron O, Daval M, Hainault I, Hajduch E, Servant JM, Gautier JF, Ferre P, Foufelle F. Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase. Diabetologia 2010; 53: 768-778
    CrossrefPubMedGoogle Scholar
  • 86 Grala TM, Kay JK, Walker CG, Sheahan AJ, Littlejohn MD, Lucy MC, Roche JR. Expression analysis of key somatotropic axis and liporegulatory genes in ghrelin- and obestatin-infused dairy cows. Domest Anim Endocrinol 2010; 39: 76-83
    CrossrefPubMedGoogle Scholar
  • 87 Yoshizaki T, Milne JC, Imamura T, Schenk S, Sonoda N, Babendure JL, Lu JC, Smith JJ, Jirousek MR, Olefsky JM. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol 2009; 29: 1363-1374
    CrossrefPubMedGoogle Scholar
  • 88 Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-1792
    CrossrefPubMedGoogle Scholar
  • 89 Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, Boss O, Pernin A, Chin WW, Cusin I, Rohner-Jeanrenaud F, Burger AG, Zapf J, Meier CA. Direct effects of leptin on brown and white adipose tissue. J Clin Invest 1997; 100: 2858-2864
    CrossrefPubMedGoogle Scholar
  • 90 Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007; 117: 2621-2637
    CrossrefPubMedGoogle Scholar